BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260512T080000
DTEND;TZID=Europe/Brussels:20260513T200000
DTSTAMP:20260525T100056
CREATED:20260424T101919Z
LAST-MODIFIED:20260424T101921Z
UID:9605-1778572800-1778702400@www.europabio.org
SUMMARY:EFGCP Conference 2026
DESCRIPTION:EuropaBio is supporting EFGCP Conference 2026. \n\n\n\nEurope is at a defining moment for clinical research. The Clinical Trials Regulation set out a powerful vision: a continent united by transparency\, collaboration\, and efficient access to innovation. While its implementation brought both progress and pressure\, it confirmed something essential—Europe’s commitment to ethics\, quality\, and patient protection remains unwavering. \n\n\n\nNational ethical review is a vital strength of Europe’s clinical research landscape. Ethics committees play a key role in ensuring trials uphold human dignity\, scientific integrity\, and public trust. Their contribution\, together with the regulatory authorities’ risk-benefit review\, forms the foundation of a credible and high‑quality research ecosystem. By further strengthening the collaborative partnership\, Europe can achieve an ethical review process that is both protective and efficiently aligned with the needs of modern clinical research. \n\n\n\nToday\, national ethical review stands at the centre of the conference discussion. Ethics committees face growing complexity; sponsors navigate longer reviews and more information requests. These challenges highlight not failure\, but opportunity: the chance to rethink how Europe aligns ethical excellence with operational efficiency. \n\n\n\nIn addition\, the European Commission’s proposed new Biotech Act offers a fresh pathway—clearer roles\, streamlined processes\, and modern ethical standards grounded in the 2024 Declaration of Helsinki. It invites us to shape a system worthy of Europe’s innovation leadership ambitions. \n\n\n\nThe EFGCP Conference 2026 is where this work begins. Here\, stakeholders from across Europe come together to share best practice experiences\, challenge assumptions\, and co‑create practical solutions to optimise the system. Our goal is simple and ambitious: to strengthen participant protection while enabling efficient\, faster\, more predictable clinical trial authorisations and start up times. \n\n\n\nTogether\, we have the opportunity to build an ethical review model that reflects Europe at its best—responsible\, collaborative\, transparent and ready to lead the next chapter of global research. \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/efgcp-conference-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website.png
END:VEVENT
END:VCALENDAR